TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9390111

Group type: EXPERIMENTAL
Intervention: SDZ HTF 919 25 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SDZ HTF 919 100 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SDZ HTF 919 1 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: SDZ HTF 919 5 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 7962372

Group type: EXPERIMENTAL
Intervention: Classical vaporization of the ovarian capsule (22 women)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Simple perforation of the ovarian capsule with subcapsular destruction of the ovarian stroma (22 women)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Overall conception rate after laparoscopic argon laser treatment
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate therapy post-operatively
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Overall conception rate
Number of subjects: 44
Study: 3308477

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Metoclopramide (MTC)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Domperidone (DMP)
Number of subjects: 62
Study: 29618098

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTi)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control
Number of subjects: 151
Study: 28642082

Group type: EXPERIMENTAL
Intervention: 50,000IU vitamin D supplements
Number of subjects: 68
Study: 26327975

Group type: EXPERIMENTAL
Intervention: Prenatal contraceptive counselling (home visits and telephone consultations)
Number of subjects: 1385

Group type: COMPARATOR
Intervention: Routine antenatal care (control group)
Number of subjects: 1385

Group type: EXPERIMENTAL
Intervention: Prenatal contraceptive counselling (intervention group)
Number of subjects: 1385
Study: 24246825

Group type: EXPERIMENTAL
Intervention: Corneas from donors aged 12 to 65 years
Number of subjects: 1090

Group type: COMPARATOR
Intervention: Corneas from donors aged 66 to 75 years
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Donors aged 34 to 71 years
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Donors aged 12 to 33 years
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Donors aged 72 to 75 years
Number of subjects: 1090
Study: 21143245

Group type: EXPERIMENTAL
Intervention: Greater subjective alcohol intoxication
Number of subjects: 1867

Group type: EXPERIMENTAL
Intervention: Lighter drinking
Number of subjects: 1867

Group type: EXPERIMENTAL
Intervention: Family history of alcohol problems
Number of subjects: 1867

Group type: EXPERIMENTAL
Intervention: Higher estimated blood alcohol concentrations (eBACs)
Number of subjects: 1867

Group type: EXPERIMENTAL
Intervention: Students with greater subjective intoxication
Number of subjects: 1867
Study: 18258620

Group type: EXPERIMENTAL
Intervention: MUFAs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CHO/N3
Number of subjects: 20

Group type: COMPARATOR
Intervention: SFAs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fatty meals (SFA, MUFA, CHO/N3)
Number of subjects: 20
Study: 17033039

Group type: EXPERIMENTAL
Intervention: Docetaxel 60 mg/m2
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m2
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Docetaxel 100 mg/m2
Number of subjects: 527

Group type: COMPARATOR
Intervention: Docetaxel (all doses)
Number of subjects: 527
Study: 14585088

Group type: EXPERIMENTAL
Intervention: Training program (8 weeks of supervised endurance exercise, 75% VO(2peak), 45 min twice a week, with intermittent exercise once a week)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Training program
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 10922194

Group type: EXPERIMENTAL
Intervention: Oral acyclovir, 800 mg/d
Number of subjects: 703

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 703
Study: 8883650

Group type: EXPERIMENTAL
Intervention: Fast FLAIR imaging
Number of subjects: 45

Group type: COMPARATOR
Intervention: T1-, proton density-, and T2-weighted images
Number of subjects: 45
Study: 1565752

Group type: EXPERIMENTAL
Intervention: NEG emotion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: POS emotion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Speech alone
Number of subjects: 20
Study: 30803168

Group type: EXPERIMENTAL
Intervention: Intestinal preparation with polyethylene glycol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Non intestinal preparation
Number of subjects: 120
Study: 28686338

Group type: EXPERIMENTAL
Intervention: CIMT applied early (within 28 days post-stroke)
Number of subjects: 47

Group type: COMPARATOR
Intervention: CIMT applied late (6 months post-stroke)
Number of subjects: 47
Study: 27103154

Group type: EXPERIMENTAL
Intervention: Web-based computer-tailored intervention (game with tailored feedback on alcohol awareness)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 0
Study: 25491714

Group type: EXPERIMENTAL
Intervention: Brief educational and counseling intervention
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Testing for chlamydia and gonorrhea
Number of subjects: 171
Study: 21939591

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy for psychosis (CBT-P)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 19584345

Group type: EXPERIMENTAL
Intervention: 2-dose PCV-7 schedule (2 and 4 months)
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: 2 + 1-dose PCV-7 schedule (2, 4, and 11 months)
Number of subjects: 1003

Group type: COMPARATOR
Intervention: Control group (no dosage)
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: 2 + 1-dose PCV-7 schedule
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: 2-dose PCV-7 schedule
Number of subjects: 1003
Study: 18240275

Group type: EXPERIMENTAL
Intervention: 300 mg antofloxacin hydrochloride
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 mg antofloxacin hydrochloride
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 500 mg antofloxacin hydrochloride
Number of subjects: 12
Study: 16015377

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 2501

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2501
Study: 14562857

Group type: EXPERIMENTAL
Intervention: Nevirapine-containing regimens
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Triple drug regimens containing Nevirapine
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Regimens containing didanosine and stavudine plus indinavir or Nevirapine
Number of subjects: 96
Study: 10474140

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8899318

Group type: EXPERIMENTAL
Intervention: Ukrain treatment in preoperative phase
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no Ukrain treatment)
Number of subjects: 18
Study: 1844999

Group type: EXPERIMENTAL
Intervention: Polylactate (PL: 80% polylactate, 20% sodium lactate, in 7% solution with water)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Glucose polymer (GP: multidextrin in 7% solution with water)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (C: water sweetened with aspartame)
Number of subjects: 5
Study: 6097377

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg p.o.) in acute studies
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Enalapril titrated from 5 mg to 20 mg twice a day in chronic studies
Number of subjects: 23
Study: 30665383

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 29898055

Group type: EXPERIMENTAL
Intervention: GI - enamel microabrasion
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: GII - microabrasion associated with at-home bleaching
Number of subjects: 70

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 70

Group type: COMPARATOR
Intervention: Whole sample
Number of subjects: 70
Study: 27127325

Group type: EXPERIMENTAL
Intervention: SRP + AZM tablets
Number of subjects: 40

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: AZM patch monotherapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: AZM tablet as monotherapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SRP + AZM patch
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SRP + AZM tablet
Number of subjects: 40
Study: 25444588

Group type: EXPERIMENTAL
Intervention: Transcranial static magnetic field stimulation (tSMS) for 10 and 15 min
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Transcranial static magnetic field stimulation (tSMS) applied while recording SEPs every 3 min for 15 min
Number of subjects: 10
Study: 21956486

Group type: EXPERIMENTAL
Intervention: Small-sided street soccer (2.2 ± 0.7 sessions/week)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Waiting list control (0.5 ± 0.2 sessions/week)
Number of subjects: 32
Study: 19161955

Group type: EXPERIMENTAL
Intervention: Sunflower Therapy
Number of subjects: 0
Study: 17313701

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of pancreatic polypeptide (PP) at 5 pmol/kg per min
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: PP infusion
Number of subjects: 14
Study: 15356657

Group type: EXPERIMENTAL
Intervention: Low-dose etoposide (50 mg/m² per day) administered orally as a single agent for 7 days
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Low-dose etoposide (50 mg/m² per day) administered orally
Number of subjects: 45
Study: 11254520

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 49) with a respiratory therapist‐driven weaning protocol including daily screens and spontaneous breathing trials (SBT) for 2 hours.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (n = 51) with standard care.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overall outcomes for both groups.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: GCS score as a predictor of extubation success.
Number of subjects: 100
Study: 9637578

Group type: EXPERIMENTAL
Intervention: Interactive health education groups (N=34)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Usual-care control group (N=37)
Number of subjects: 71
Study: 8207324

Group type: EXPERIMENTAL
Intervention: Lacrisomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluorescein-hydrated Collasomes in methylcellulose vehicle
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study: 2521471

Group type: EXPERIMENTAL
Intervention: Cimetidine 1.5 gm a day for 3 months
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (8 women)
Number of subjects: 12
Study: 1153148

Group type: EXPERIMENTAL
Intervention: DMPA (Depo-Provera, Upjohn) 150 mg IM monthly
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sterile saline 1.5 ml IM monthly (Control)
Number of subjects: 57
Study: 31837640

Group type: EXPERIMENTAL
Intervention: Zinc (30 mg/d)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Vitamin D (2000 IU/d)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Zinc (30 mg/d) + Vitamin D (2000 IU/d)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo (Vitamin D placebo + Zinc placebo)
Number of subjects: 140
Study: 30232789

Group type: EXPERIMENTAL
Intervention: ACTH
Number of subjects: 33

Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 33
Study: 28494777

Group type: EXPERIMENTAL
Intervention: Antimicrobial therapy plus oseltamivir
Number of subjects: 127

Group type: COMPARATOR
Intervention: Antimicrobial therapy alone (control group)
Number of subjects: 127
Study: 25602059

Group type: EXPERIMENTAL
Intervention: Intra‐atrial lateral tunnel (ILT)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Extracardiac conduit (ECC)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Holter recordings
Number of subjects: 115
Study: 23781882

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (group A)
Number of subjects: 40
Study: 21226960

Group type: EXPERIMENTAL
Intervention: Self-help coping advice emails (twice weekly for six weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: General information about depression emails (twice weekly for six weeks)
Number of subjects: 0
Study: 18157642

Group type: EXPERIMENTAL
Intervention: Transurethral collagen injection midurethrally
Number of subjects: 30

Group type: COMPARATOR
Intervention: Transurethral collagen injection at the bladder neck
Number of subjects: 30
Study: 16827020

Group type: EXPERIMENTAL
Intervention: Base with a polyacid‐modified resin composite: F2000
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Base with a resin‐modified glass‐ionomer cement: Vitrebond
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control: no base
Number of subjects: 18
Study: 12859559

Group type: EXPERIMENTAL
Intervention: HDM intervention (allergen impermeable mattress covers and acaricidal washing detergent for bedding)
Number of subjects: 616

Group type: COMPARATOR
Intervention: Control group (no special recommendations)
Number of subjects: 616
Study: 10757257

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0
Study: 8785393

Group type: EXPERIMENTAL
Intervention: Ramped hypertonic sodium dialysis (RHSD)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard dialysis (SD)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Long-term RHSD therapy
Number of subjects: 16
Study: 1948517

Group type: EXPERIMENTAL
Intervention: Ceftizoxime 250 mg IM
Number of subjects: 204

Group type: COMPARATOR
Intervention: Ceftriaxone 250 mg IM
Number of subjects: 204
Study: 6666222

Group type: EXPERIMENTAL
Intervention: 60 mg ISDN sr
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 9
Study: 30659468

Group type: EXPERIMENTAL
Intervention: New standard operating procedure (SOP) using a combination of esketamine and propofol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conscious sedation (CS) from the SIESTA trial
Number of subjects: 0
Study: 30231074

Group type: EXPERIMENTAL
Intervention: In-vehicle exposure to particulate metals (Al, Pb, Fe) during a highway commute
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: In-vehicle exposure to particulate metals (Al, Pb, Fe)
Number of subjects: 60
Study: 28110894

Group type: EXPERIMENTAL
Intervention: High-risk patients (hs-CRP ≥3.84mg/L and Lp-PLA2 >239μg/L)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Low-to-intermediate-risk patients
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: High-risk patients
Number of subjects: 68
Study: 25898791

Group type: EXPERIMENTAL
Intervention: MIPO with appositional screw fixation (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: MIPO without appositional screw fixation (group A)
Number of subjects: 60
Study: 23283254

Group type: EXPERIMENTAL
Intervention: Vapocoolant spray
Number of subjects: 95

Group type: COMPARATOR
Intervention: Topical ice pack
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 95
Study: 20817429

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone (ITD)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 66
Study: 18292451

Group type: EXPERIMENTAL
Intervention: Patient-controlled continuous interscalene block (PCISB)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Patient-controlled i.v. (opioid) analgesia (PCA)
Number of subjects: 87
Study: 17088191

Group type: EXPERIMENTAL
Intervention: Combined anterior-posterior fusion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Posterior-only fusion
Number of subjects: 100
Study: 12644417

Group type: EXPERIMENTAL
Intervention: English laryngoscope blade
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard laryngoscope blade
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both blades
Number of subjects: 300
Study: 11021442

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite‐coated Freeman‐Samuelson (FS HA) total knee arthroplasty
Number of subjects: 51

Group type: COMPARATOR
Intervention: Porous‐coated Miller‐Galante II (MG II) total knee arthroplasty
Number of subjects: 51
Study: 9070551

Group type: COMPARATOR
Intervention: Trandolapril 1 mg/day for 1 month and 2 mg/day for the following 2 months (n = 49)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Trandolapril 1 mg/day for 1 month and 2 mg/day for the following 2 months plus Verapamil 240 mg/day for 1 month and 360 mg/day for 2 months (n = 51)
Number of subjects: 100
Study: 12959317

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (600 mg) in patients on phenobarbitone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (600 mg) in patients on sodium valproate
Number of subjects: 16

Group type: COMPARATOR
Intervention: Oxcarbazepine (600 mg) in healthy control subjects
Number of subjects: 16
Study: 3772833

Group type: EXPERIMENTAL
Intervention: Strong buzzer condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mild buzzer condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conscious and unstressful condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strong emotion
Number of subjects: 0
Study: 31758920

Group type: EXPERIMENTAL
Intervention: Drospirenone (DRSP) 4 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Drospirenone (DRSP) 3 mg and Ethinyl Estradiol (EE) 0.02 mg
Number of subjects: 24
Study: 29909977

Group type: EXPERIMENTAL
Intervention: Radioactive Bare Metal Stent (RBMS)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional Bare Metal Stent (CBMS)
Number of subjects: 66
Study: 26493792

Group type: EXPERIMENTAL
Intervention: DASH behavioural intervention (n=46)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual-care control (n=44)
Number of subjects: 90
Study: 24906459

Group type: EXPERIMENTAL
Intervention: Exercise dose for general health (8 kcal/kg body weight per week, about 900 kcal/wk)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Exercise dose for weight loss (20 kcal/kg body weight per week, about 2,250 kcal/wk)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Non-exercise control group receiving health information only
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 198
Study: 23770788

Group type: EXPERIMENTAL
Intervention: Allopurinol (10 mg/kg body weight, 3 times before operation)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Allopurinol and Placebo
Number of subjects: 26
Study: 21364503

Group type: EXPERIMENTAL
Intervention: Lidocaine 40 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil 50 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lidocaine 40 mg and Flurbiprofen axetil 50 mg (combination)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 100
Study: 18485028

Group type: COMPARATOR
Intervention: Docetaxel 70 mg/m² on day 1 (arm A)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Docetaxel 70 mg/m² on day 2 plus oral estramustine phosphate (EP) 840 mg total daily dose on days 1-5 (arm B)
Number of subjects: 95
Study: 16455821

Group type: EXPERIMENTAL
Intervention: Intervention schools received staff asthma-training session, advice on asthma policy, an emergency beta2-agonist inhaler with spacer, and whole-class asthma workshops.
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 193

Group type: COMPARATOR
Intervention: Nonintervention group
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Intervention and Nonintervention groups
Number of subjects: 193
Study: 14553956

Group type: EXPERIMENTAL
Intervention: Lisinopril (0.07 mg/kg once daily)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 11061364

Group type: EXPERIMENTAL
Intervention: Cilazapril 20 mg/day
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 8931406

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 115

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Prior antibiotics
Number of subjects: 115
Study: 1524682

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine rinse (Peridex)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 94
Study: 2439798

Group type: EXPERIMENTAL
Intervention: bisoprolol (0.07 mg/kg i.v.)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: metoprolol (0.2 mg/kg i.v.)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: acebutolol (0.8 mg/kg i.v.)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: penbutolol (0.04 mg/kg i.v.)
Number of subjects: 16

Group type: COMPARATOR
Intervention: propranolol (0.2 mg/kg i.v.)
Number of subjects: 16
Study: 31306389

Group type: EXPERIMENTAL
Intervention: High-volume (HV) training group
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Low-volume (LV) training group
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study: 29462223

Group type: EXPERIMENTAL
Intervention: Dapsone gel, 7.5%
Number of subjects: 4327

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 4327
Study: 27267154

Group type: EXPERIMENTAL
Intervention: Depression-prevention, resilience promotion program
Number of subjects: 264

Group type: COMPARATOR
Intervention: Advanced diabetes education program
Number of subjects: 264
Study: 24313546

Group type: EXPERIMENTAL
Intervention: PPS-guided stress management programme
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control cluster group
Number of subjects: 42
Study: 20597141

Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg/day over 24 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16002019

Group type: EXPERIMENTAL
Intervention: Single-dose oral ciprofloxacin (500 mg)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Single-dose intravenous cefazolin (1g)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 395
Study: 12022620

Group type: COMPARATOR
Intervention: Magnetization transfer ratio (MTR) histogram analysis using linear discriminant analysis (LDA) for classification of MS subgroups.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Principal component analysis (PCA) for correlation with current disability measured by the EDSS scale.
Number of subjects: 0